Thermo Fisher Scientific (TMO) Deferred Taxes (2009 - 2026)

Thermo Fisher Scientific has reported Deferred Taxes for 18 years, with the latest figure at -$208.0 million in Q2 2026.

• Deferred Taxes for Q2 2026 came in at -$208.0 million, up 35.4% year-over-year; the trailing twelve-month figure through Jun 2026 was -$504.0 million (up 58.1% YoY), and the FY2025 annual result was -$639.0 million, up 47.15% from the prior year.
• Deferred Taxes improved to -$208.0 million in Q2 2026, from -$258.0 million in the prior quarter.
• Over five years, Deferred Taxes peaked at $339.0 million in Q2 2022 and troughed at -$1.9 billion in Q4 2023.
• A 5-year average of -$145.5 million and a median of -$19.0 million in 2025 frame the typical range for Deferred Taxes.
• The widest annual swing landed in 2022, when Deferred Taxes jumped 1512.5%; it then plunged 1551.88% in 2023.
• A 5-year view of Deferred Taxes shows it stood at $133.0 million in 2022, then plunged by 1551.88% to -$1.9 billion in 2023, then soared by 89.54% to -$202.0 million in 2024, then soared by 144.06% to $89.0 million in 2025, then plunged by 333.71% to -$208.0 million in 2026.
• Per Business Quant data, the three most recent Deferred Taxes figures were -$208.0 million in Q2 2026, -$258.0 million in Q1 2026, and $89.0 million in Q4 2025.